Can we be satisfied with progress on children’s cancer?

A new analysis of the impact of European regulations designed to bring through new treatments for children with cancer has expressed disappointment at the speed of progress. The ICR’s Dr Eva Sharpe finds out more.
Institute of Cancer Research